Medications

Japanese firm buys US pharmaceutical company

(AP)—A Japanese pharmaceutical company is acquiring LigoCyte Pharmaceuticals in a $60 million deal to expand its vaccine division, Takeda Pharmaceutical Co. announced.

Medications

Indian firm unveils latest typhoid shots

An Indian pharmaceutical firm said Thursday it would soon launch the world's first vaccine against typhoid which can be given to infants, protecting the most vulnerable victims of the illness.

Health

Five key points in proposed pandemic agreement

Countries are trying to finalize a global agreement on how to prepare for and avert pandemics by Friday evening, after two years of negotiations triggered by the horrors of COVID-19.

Medications

Valeant agrees to pay about $2.6B for Medicis

(AP)—Valeant Pharmaceuticals International Inc. has agreed to buy dermatology products maker Medicis Pharmaceutical Corp. for about $2.6 billion in cash in a deal to strengthen its position in skin treatments and care.

Medications

Joint search for new antibiotics

The WHO has identified antibiotic resistance as one of the three biggest threats to human health. Without new antibiotics, we risk returning to a situation in which every infection is life-threatening. The combined expertise ...

Medications

BioAnalytix advances the biologic drug development

Biologic drugs are highly complex, but they may be the answer to many medical illnesses and conditions that currently have no treatment available. The problem is, these drugs are not easy to characterize and test. Unlike ...

page 6 from 8